A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...

GoodRx Holdings Inc (NASDAQ:GDRX) stock edged up 1.7% in premarket trading Monday after the medication savings platform announced two major initiatives to make GLP-1 weight loss medications more ...

GoodRx’s third quarter results were met with a moderate positive market response, as the company’s revenue modestly exceeded Wall Street expectations despite being flat year-over-year. Management ...

The average cost among our picks for the best pet insurance companies is $47.87 per month. Pets Best has the lowest average ...

Open enrollment is here, which means it's time to review your health coverage options for 2026 and make changes if you need to. With a little prep, choosing a plan through Medicare, your employer or ...

Hobbs on Monday rolled out AZRx, the state’s implementation of the ArrayRx Discount Card, positioning it as a free, state‑backed prescription discount that differs from private services like GoodRx.

GoodRx Holdings Inc (GDRX) reports robust growth in manufacturer solutions but faces headwinds from prescription revenue decline and market uncertainties.

Novo Nordisk announced that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients.

Business Insider's exclusive analysis shows colon cancer in your 30s can cost $45,000 in one year alone. We break it down, dollar by dollar.

Social Security beneficiaries will receive a 2.8% bump in benefits in 2026, but health care alone may eat up their extra ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...